Nasdaq · CIK 0001763950
LTRN Lantern Pharma Inc.
Insider trading from SEC Form 4. Last filing Dec 22, 2025. Close $0.81 on Oct 9, 2026, 0% from the 52-week low and -82% from the high.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
9
with a Form 4 at this company
Price and insider trades, last year
LTRNOct 9, 2026 · close 0.81
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Lantern Pharma Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 42Moderate | Aaron G.L. Fletcher owner sell | $208k 61,613 shares | -30% | - | |
| 35Weak | Aaron G.L. Fletcher owner sell | $124k 40,000 shares | -20% | - | |
| 42Moderate | Leslie W. Kreis owner sell | $208k 61,613 shares | -30% | - | |
| 35Weak | Leslie W. Kreis owner sell | $124k 40,000 shares | -20% | - | |
| 41Moderate | Aaron G.L. Fletcher owner sell | $168k 56,237 shares | -26% | - | |
| 41Moderate | Leslie W. Kreis owner sell | $168k 56,237 shares | -26% | - |
Transactions
The last 94 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 18, 2025 | Kishor G. Bhatia Chief Scientific Officer | AGrant or award Stock Option (Right to Buy)derivative | +10,000 | $0.00 | $0 | 10,000 | Dec 22, 2025 |
| Jun 15, 2020 | Kishor G. Bhatia Chief Scientific Officer | DDisposition to issuer Stock Option (Right to Buy)derivative | -52,200 | $0.00 | $0 | 0 | Sep 23, 2025 |
| Jun 15, 2020 | Panna Sharma President & CEO | DDisposition to issuer Stock Option (Right to Buy)derivative | -76,628 | $0.00 | $0 | 0 | Sep 23, 2025 |
| Jun 15, 2020 | Vijay Chandru director | DDisposition to issuer Stock Option (Right to Buy)derivative | -9,135 | $0.00 | $0 | 0 | Sep 23, 2025 |
| Jun 15, 2020 | David R. Margrave Chief Financial Officer | DDisposition to issuer Stock Option (Right to Buy)derivative | -78,300 | $0.00 | $0 | 0 | Sep 23, 2025 |
| Jun 15, 2020 | David S. Silberstein director | DDisposition to issuer Stock Option (Right to Buy)derivative | -9,135 | $0.00 | $0 | 0 | Sep 23, 2025 |
| Jun 15, 2020 | D Jeffrey Keyser director | DDisposition to issuer Stock Option (Right to Buy)derivative | -9,135 | $0.00 | $0 | 0 | Sep 23, 2025 |
| Jun 15, 2020 | Kishor G. Bhatia Chief Scientific Officer | AGrant or award Stock Option (Right to Buy)derivative | +52,200 | $0.00 | $0 | 52,200 | Sep 23, 2025 |
| Jun 15, 2020 | Vijay Chandru director | AGrant or award Stock Option (Right to Buy)derivative | +9,135 | $0.00 | $0 | 9,135 | Sep 23, 2025 |
| Jun 15, 2020 | D Jeffrey Keyser director | AGrant or award Stock Option (Right to Buy)derivative | +9,135 | $0.00 | $0 | 9,135 | Sep 23, 2025 |
| Jun 15, 2020 | David S. Silberstein director | AGrant or award Stock Option (Right to Buy)derivative | +9,135 | $0.00 | $0 | 9,135 | Sep 23, 2025 |
| Jun 15, 2020 | David R. Margrave Chief Financial Officer | AGrant or award Stock Option (Right to Buy)derivative | +78,300 | $0.00 | $0 | 78,300 | Sep 23, 2025 |
| Jun 15, 2020 | Panna Sharma President & CEO | AGrant or award Stock Option (Right to Buy)derivative | +76,628 | $0.00 | $0 | 76,628 | Sep 23, 2025 |
| Oct 29, 2021 | David R. Margrave Chief Financial Officer | DDisposition to issuer Stock Option (Right to Buy)derivative | -26,100 | $0.00 | $0 | 0 | Sep 23, 2025 |
| Oct 29, 2021 | Kishor G. Bhatia Chief Scientific Officer | DDisposition to issuer Stock Option (Right to Buy)derivative | -17,400 | $0.00 | $0 | 0 | Sep 23, 2025 |
| Nov 4, 2021 | David S. Silberstein director | DDisposition to issuer Stock Option (Right to Buy)derivative | -3,200 | $0.00 | $0 | 0 | Sep 23, 2025 |
| Nov 4, 2021 | D Jeffrey Keyser director | DDisposition to issuer Stock Option (Right to Buy)derivative | -3,200 | $0.00 | $0 | 0 | Sep 23, 2025 |
| Nov 4, 2021 | Vijay Chandru director | DDisposition to issuer Stock Option (Right to Buy)derivative | -3,200 | $0.00 | $0 | 0 | Sep 23, 2025 |
| Oct 29, 2021 | David R. Margrave Chief Financial Officer | AGrant or award Stock Option (Right to Buy)derivative | +26,100 | $0.00 | $0 | 26,100 | Sep 23, 2025 |
| Oct 29, 2021 | Kishor G. Bhatia Chief Scientific Officer | AGrant or award Stock Option (Right to Buy)derivative | +17,400 | $0.00 | $0 | 17,400 | Sep 23, 2025 |
| Nov 4, 2021 | David S. Silberstein director | AGrant or award Stock Option (Right to Buy)derivative | +3,200 | $0.00 | $0 | 3,200 | Sep 23, 2025 |
| Nov 4, 2021 | D Jeffrey Keyser director | AGrant or award Stock Option (Right to Buy)derivative | +3,200 | $0.00 | $0 | 3,200 | Sep 23, 2025 |
| Nov 4, 2021 | Vijay Chandru director | AGrant or award Stock Option (Right to Buy)derivative | +3,200 | $0.00 | $0 | 3,200 | Sep 23, 2025 |
| Aug 19, 2025 | Lee Troy Schalop director | AGrant or award Stock Option (Right to Buy)derivative | +5,000 | $0.00 | $0 | 5,000 | Aug 20, 2025 |
| Jun 13, 2025 | Leslie W. Kreis owner | SOpen-market sale Common Stockindirect: By Bios Fund I QP, LP | -7,206 | $3.09 | $22k | 189,117 | Jun 13, 2025 |
| Jun 13, 2025 | Aaron G.L. Fletcher owner | SOpen-market sale Common Stockindirect: By Bios Fund I QP, LP | -7,206 | $3.09 | $22k | 189,117 | Jun 13, 2025 |
| Jun 10, 2025 | Leslie W. Kreis owner | SOpen-market sale Common Stockindirect: By Bios Fund I QP, LP | -3 | $3.40 | $10 | 207,419 | Jun 13, 2025 |
| Jun 10, 2025 | Aaron G.L. Fletcher owner | SOpen-market sale Common Stockindirect: By Bios Fund I QP, LP | -3 | $3.40 | $10 | 207,419 | Jun 13, 2025 |
| Jun 11, 2025 | Leslie W. Kreis owner | SOpen-market sale Common Stockindirect: By Bios Fund I QP, LP | -171 | $3.40 | $581 | 207,248 | Jun 13, 2025 |
| Jun 11, 2025 | Aaron G.L. Fletcher owner | SOpen-market sale Common Stockindirect: By Bios Fund I QP, LP | -171 | $3.40 | $581 | 207,248 | Jun 13, 2025 |
| Jun 13, 2025 | Aaron G.L. Fletcher owner | SOpen-market sale Common Stockindirect: By Bios Fund I, LP | -12,319 | $3.09 | $38k | 323,335 | Jun 13, 2025 |
| Jun 13, 2025 | Leslie W. Kreis owner | SOpen-market sale Common Stockindirect: By Bios Fund I, LP | -12,319 | $3.09 | $38k | 323,335 | Jun 13, 2025 |
| Jun 12, 2025 | Aaron G.L. Fletcher owner | SOpen-market sale Common Stockindirect: By Bios Fund I QP, LP | -10,925 | $3.38 | $37k | 196,323 | Jun 13, 2025 |
| Jun 12, 2025 | Leslie W. Kreis owner | SOpen-market sale Common Stockindirect: By Bios Fund I QP, LP | -10,925 | $3.38 | $37k | 196,323 | Jun 13, 2025 |
| Jun 13, 2025 | Aaron G.L. Fletcher owner | SOpen-market sale Common Stockindirect: By Bios Fund II NT, LP | -1,903 | $3.09 | $5,880 | 49,957 | Jun 13, 2025 |
| Jun 13, 2025 | Leslie W. Kreis owner | SOpen-market sale Common Stockindirect: By Bios Fund II NT, LP | -1,903 | $3.09 | $5,880 | 49,957 | Jun 13, 2025 |
| Jun 10, 2025 | Aaron G.L. Fletcher owner | SOpen-market sale Common Stockindirect: By Bios Fund I, LP | -5 | $3.40 | $17 | 354,625 | Jun 13, 2025 |
| Jun 13, 2025 | Aaron G.L. Fletcher owner | SOpen-market sale Common Stockindirect: By Bios Fund II QP, LP | -14,218 | $3.09 | $44k | 373,178 | Jun 13, 2025 |
| Jun 10, 2025 | Leslie W. Kreis owner | SOpen-market sale Common Stockindirect: By Bios Fund I, LP | -5 | $3.40 | $17 | 354,625 | Jun 13, 2025 |
| Jun 13, 2025 | Leslie W. Kreis owner | SOpen-market sale Common Stockindirect: By Bios Fund II QP, LP | -14,218 | $3.09 | $44k | 373,178 | Jun 13, 2025 |
| Jun 13, 2025 | Leslie W. Kreis owner | SOpen-market sale Common Stockindirect: By Bios Fund II, LP | -4,354 | $3.09 | $13k | 114,272 | Jun 13, 2025 |
| Jun 13, 2025 | Aaron G.L. Fletcher owner | SOpen-market sale Common Stockindirect: by Bios Fund II, LP | -4,354 | $3.09 | $13k | 114,272 | Jun 13, 2025 |
| Jun 11, 2025 | Leslie W. Kreis owner | SOpen-market sale Common Stockindirect: By Bios Fund I, LP | -293 | $3.40 | $996 | 354,332 | Jun 13, 2025 |
| Jun 11, 2025 | Aaron G.L. Fletcher owner | SOpen-market sale Common Stockindirect: By Bios Fund I, LP | -293 | $3.40 | $996 | 354,332 | Jun 13, 2025 |
| Jun 12, 2025 | Aaron G.L. Fletcher owner | SOpen-market sale Common Stockindirect: By Bios Fund I, LP | -18,678 | $3.38 | $63k | 335,654 | Jun 13, 2025 |
| Jun 12, 2025 | Leslie W. Kreis owner | SOpen-market sale Common Stockindirect: By Bios Fund I, LP | -18,678 | $3.38 | $63k | 335,654 | Jun 13, 2025 |
| Jun 10, 2025 | Leslie W. Kreis owner | SOpen-market sale Common Stockindirect: By Bios Fund II NT, LP | -1 | $3.40 | $3 | 54,791 | Jun 13, 2025 |
| Jun 10, 2025 | Aaron G.L. Fletcher owner | SOpen-market sale Common Stockindirect: By Bios Fund II NT, LP | -1 | $3.40 | $3 | 54,791 | Jun 13, 2025 |
| Jun 11, 2025 | Leslie W. Kreis owner | SOpen-market sale Common Stockindirect: By Bios Fund II NT, LP | -45 | $3.40 | $153 | 54,746 | Jun 13, 2025 |
| Jun 11, 2025 | Aaron G.L. Fletcher owner | SOpen-market sale Common Stockindirect: By Bios Fund II NT, LP | -45 | $3.40 | $153 | 54,746 | Jun 13, 2025 |
| Jun 12, 2025 | Aaron G.L. Fletcher owner | SOpen-market sale Common Stockindirect: By Bios Fund II NT, LP | -2,886 | $3.38 | $9,755 | 51,860 | Jun 13, 2025 |
| Jun 12, 2025 | Leslie W. Kreis owner | SOpen-market sale Common Stockindirect: By Bios Fund II NT, LP | -2,886 | $3.38 | $9,755 | 51,860 | Jun 13, 2025 |
| Jun 10, 2025 | Leslie W. Kreis owner | SOpen-market sale Common Stockindirect: By Bios Fund II QP, LP | -5 | $3.40 | $17 | 409,291 | Jun 13, 2025 |
| Jun 10, 2025 | Aaron G.L. Fletcher owner | SOpen-market sale Common Stockindirect: By Bios Fund II QP, LP | -5 | $3.40 | $17 | 409,291 | Jun 13, 2025 |
| Jun 11, 2025 | Aaron G.L. Fletcher owner | SOpen-market sale Common Stockindirect: By Bios Fund II QP, LP | -338 | $3.40 | $1,149 | 408,953 | Jun 13, 2025 |
| Jun 11, 2025 | Leslie W. Kreis owner | SOpen-market sale Common Stockindirect: By Bios Fund II QP, LP | -338 | $3.40 | $1,149 | 408,953 | Jun 13, 2025 |
| Jun 12, 2025 | Aaron G.L. Fletcher owner | SOpen-market sale Common Stockindirect: By Bios Fund II QP, LP | -21,557 | $3.38 | $73k | 387,396 | Jun 13, 2025 |
| Jun 12, 2025 | Leslie W. Kreis owner | SOpen-market sale Common Stockindirect: By Bios Fund II QP, LP | -21,557 | $3.38 | $73k | 387,396 | Jun 13, 2025 |
| Jun 10, 2025 | Aaron G.L. Fletcher owner | SOpen-market sale Common Stockindirect: By Bios Fund II, LP | -2 | $3.40 | $7 | 125,330 | Jun 13, 2025 |
| Jun 10, 2025 | Leslie W. Kreis owner | SOpen-market sale Common Stockindirect: By Bios Fund II, LP | -2 | $3.40 | $7 | 125,330 | Jun 13, 2025 |
| Jun 11, 2025 | Aaron G.L. Fletcher owner | SOpen-market sale Common Stockindirect: By Bios Fund II, LP | -103 | $3.40 | $350 | 125,227 | Jun 13, 2025 |
| Jun 11, 2025 | Leslie W. Kreis owner | SOpen-market sale Common Stockindirect: By Bios Fund II, LP | -103 | $3.40 | $350 | 125,227 | Jun 13, 2025 |
| Jun 12, 2025 | Leslie W. Kreis owner | SOpen-market sale Common Stockindirect: By Bios Fund II, LP | -6,601 | $3.38 | $22k | 118,626 | Jun 13, 2025 |
| Jun 12, 2025 | Aaron G.L. Fletcher owner | SOpen-market sale Common Stockindirect: By Bios Fund II, LP | -6,601 | $3.38 | $22k | 118,626 | Jun 13, 2025 |
| May 27, 2025 | Leslie W. Kreis owner | SOpen-market sale Common Stockindirect: By Bios Fund I QP, LP | -3,790 | $3.05 | $12k | 213,763 | May 29, 2025 |
| May 27, 2025 | Aaron G.L. Fletcher owner | SOpen-market sale Common Stockindirect: By Bios Fund I QP, LP | -3,790 | $3.05 | $12k | 213,763 | May 29, 2025 |
| May 28, 2025 | Leslie W. Kreis owner | SOpen-market sale Common Stockindirect: By Bios Fund I QP, LP | -2,702 | $2.87 | $7,755 | 211,061 | May 29, 2025 |
| May 28, 2025 | Aaron G.L. Fletcher owner | SOpen-market sale Common Stockindirect: By Bios Fund I QP, LP | -2,702 | $2.87 | $7,755 | 211,061 | May 29, 2025 |
| May 29, 2025 | Leslie W. Kreis owner | SOpen-market sale Common Stockindirect: By Bios Fund I QP, LP | -3,639 | $3.03 | $11k | 207,422 | May 29, 2025 |
| May 29, 2025 | Aaron G.L. Fletcher owner | SOpen-market sale Common Stockindirect: By Bios Fund I QP, LP | -3,639 | $3.03 | $11k | 207,422 | May 29, 2025 |
| May 27, 2025 | Leslie W. Kreis owner | SOpen-market sale Common Stockindirect: By Bios Fund I, LP | -6,479 | $3.05 | $20k | 365,471 | May 29, 2025 |
| May 27, 2025 | Aaron G.L. Fletcher owner | SOpen-market sale Common Stockindirect: By Bios Fund I, LP | -6,479 | $3.05 | $20k | 365,471 | May 29, 2025 |
| May 28, 2025 | Leslie W. Kreis owner | SOpen-market sale Common Stockindirect: By Bios Fund I, LP | -4,620 | $2.87 | $13k | 360,851 | May 29, 2025 |
| May 28, 2025 | Aaron G.L. Fletcher owner | SOpen-market sale Common Stockindirect: By Bios Fund I, LP | -4,620 | $2.87 | $13k | 360,851 | May 29, 2025 |
| May 29, 2025 | Leslie W. Kreis owner | SOpen-market sale Common Stockindirect: By Bios Fund I, LP | -6,221 | $3.03 | $19k | 354,630 | May 29, 2025 |
| May 29, 2025 | Aaron G.L. Fletcher owner | SOpen-market sale Common Stockindirect: By Bios Fund I, LP | -6,221 | $3.03 | $19k | 354,630 | May 29, 2025 |
| May 27, 2025 | Leslie W. Kreis owner | SOpen-market sale Common Stockindirect: By Bios Fund II NT, LP | -1,000 | $3.05 | $3,050 | 56,467 | May 29, 2025 |
| May 27, 2025 | Aaron G.L. Fletcher owner | SOpen-market sale Common Stockindirect: By Bios Fund II NT, LP | -1,000 | $3.05 | $3,050 | 56,467 | May 29, 2025 |
| May 28, 2025 | Aaron G.L. Fletcher owner | SOpen-market sale Common Stockindirect: By Bios Fund II NT, LP | -714 | $2.87 | $2,049 | 55,753 | May 29, 2025 |
| May 28, 2025 | Leslie W. Kreis owner | SOpen-market sale Common Stockindirect: By Bios Fund II NT, LP | -714 | $2.87 | $2,049 | 55,753 | May 29, 2025 |
| May 29, 2025 | Aaron G.L. Fletcher owner | SOpen-market sale Common Stockindirect: By Bios Fund II NT, LP | -961 | $3.03 | $2,912 | 54,792 | May 29, 2025 |
| May 29, 2025 | Leslie W. Kreis owner | SOpen-market sale Common Stockindirect: By Bios Fund II NT, LP | -961 | $3.03 | $2,912 | 54,792 | May 29, 2025 |
| May 27, 2025 | Aaron G.L. Fletcher owner | SOpen-market sale Common Stockindirect: By Bios Fund II QP, LP | -7,478 | $3.05 | $23k | 421,808 | May 29, 2025 |
| May 27, 2025 | Leslie W. Kreis owner | SOpen-market sale Common Stockindirect: By Bios Fund II QP, LP | -7,478 | $3.05 | $23k | 421,808 | May 29, 2025 |
| May 28, 2025 | Aaron G.L. Fletcher owner | SOpen-market sale Common Stockindirect: By Bios Fund II QP, LP | -5,332 | $2.87 | $15k | 416,476 | May 29, 2025 |
| May 28, 2025 | Leslie W. Kreis owner | SOpen-market sale Common Stockindirect: By Bios Fund II QP, LP | -5,332 | $2.87 | $15k | 416,476 | May 29, 2025 |
| May 29, 2025 | Aaron G.L. Fletcher owner | SOpen-market sale Common Stockindirect: By Bios Fund II QP, LP | -7,180 | $3.03 | $22k | 409,296 | May 29, 2025 |
| May 29, 2025 | Leslie W. Kreis owner | SOpen-market sale Common Stockindirect: By Bios Fund II QP, LP | -7,180 | $3.03 | $22k | 409,296 | May 29, 2025 |
| May 27, 2025 | Leslie W. Kreis owner | SOpen-market sale Common Stockindirect: By Bios Fund II, LP | -2,290 | $3.05 | $6,985 | 129,163 | May 29, 2025 |
| May 27, 2025 | Aaron G.L. Fletcher owner | SOpen-market sale Common Stockindirect: By Bios Fund II, LP | -2,290 | $3.05 | $6,985 | 129,163 | May 29, 2025 |
| May 28, 2025 | Leslie W. Kreis owner | SOpen-market sale Common Stockindirect: By Bios Fund II, LP | -1,632 | $2.87 | $4,684 | 127,531 | May 29, 2025 |
| May 28, 2025 | Aaron G.L. Fletcher owner | SOpen-market sale Common Stockindirect: By Bios Fund II, LP | -1,632 | $2.87 | $4,684 | 127,531 | May 29, 2025 |
| May 29, 2025 | Aaron G.L. Fletcher owner | SOpen-market sale Common Stockindirect: By Bios Fund II, LP | -2,199 | $3.03 | $6,663 | 125,332 | May 29, 2025 |
| May 29, 2025 | Leslie W. Kreis owner | SOpen-market sale Common Stockindirect: By Bios Fund II, LP | -2,199 | $3.03 | $6,663 | 125,332 | May 29, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Kishor G. BhatiaChief Scientific Officer
- Vijay Chandrudirector
- Aaron G.L. Fletcherowner, director
- D Jeffrey Keyserdirector
- Leslie W. Kreisowner, director
- David R. MargraveChief Financial Officer
- Panna SharmaPresident & CEO
- Lee Troy Schalopdirector
- David S. Silbersteindirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.